These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21044127)

  • 1. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
    Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
    Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 and IFN-γ gene expression in chronic Chagas disease patients after in vitro stimulation with recombinant antigens of Trypanosoma cruzi.
    de Melo AS; de Lorena VM; de Moura Braz SC; Docena C; de Miranda Gomes Y
    Cytokine; 2012 May; 58(2):207-12. PubMed ID: 22325340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of IgA antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi differentiate digestive forms of Chagas disease.
    Vasconcelos RH; Amaral FN; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2010 Oct; 71(10):964-7. PubMed ID: 20659514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin M antibodies against CRA and FRA recombinant antigens of Trypanosoma cruzi in chronic chagasic patients.
    Vasconcelos RH; Azevedo EA; Cavalcanti MG; Silva ED; Ferreira AG; Morais CN; Gomes YM
    Hum Immunol; 2011 May; 72(5):402-5. PubMed ID: 21371515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.
    Lorena VM; Verçosa AF; Machado RC; Moitinho-Silva L; Cavalcanti MG; Silva ED; Ferreira AG; Correa-Oliveira R; Pereira VR; Gomes YM
    J Clin Lab Anal; 2008; 22(2):91-8. PubMed ID: 18348314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
    Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
    Gomes JA; Campi-Azevedo AC; Teixeira-Carvalho A; Silveira-Lemos D; Vitelli-Avelar D; Sathler-Avelar R; Peruhype-Magalhães V; Silvestre KF; Batista MA; Schachnik NC; Correa-Oliveira R; Eloi-Santos S; Martins-Filho OA
    Immunobiology; 2012 Oct; 217(10):1005-16. PubMed ID: 22387073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.
    Gomes JA; Bahia-Oliveira LM; Rocha MO; Busek SC; Teixeira MM; Silva JS; Correa-Oliveira R
    Infect Immun; 2005 Dec; 73(12):7960-6. PubMed ID: 16299288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
    Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.
    Medeiros NI; Fares RC; Franco EP; Sousa GR; Mattos RT; Chaves AT; Nunes MD; Dutra WO; Correa-Oliveira R; Rocha MO; Gomes JA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005284. PubMed ID: 28118356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.
    de Moura Braz SC; de Melo AS; da Glória Aureliano de Melo Cavalcanti M; Martins SM; de Oliveira W; da Silva ED; Ferreira AG; de Lorena VM; de Miranda Gomes Y
    J Clin Immunol; 2014 Nov; 34(8):991-8. PubMed ID: 25205548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
    Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
    J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
    Laucella SA; Rottenberg ME; de Titto EH
    Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and bystander suppression induced by membrane and flagellar antigens of Trypanosoma cruzi.
    Mosca W; Briceño L
    Invest Clin; 2009 Mar; 50(1):77-87. PubMed ID: 19418729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
    Van Voorhis WC
    J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.